Skip to main content

AGENDA

Fairmont Hotel Lake Louise

FRIDAY, MARCH 22, 2024

ALLIED HEALTH Professionals Program – Mt. Temple Ballroom
1200 – 1545h ALLIED HEALTH Professionals Program
1200 – 1245h Decoding Clinical Research: A Primer on Statistics Looking at Recent Lymphoproliferative Trials to Review – Ms. Cindy Railton, NP
1245 – 1330h Take Home Chemotherapy – Bortezomib for Myeloma – Dr. Jason Tay
1330 – 1415h Chronicity Concerns in Lymphoproliferative Disorders – Dr. Edith Pituskin, NP
1415 – 1500h Transitioning to Palliative Care – A Guide to Difficult Conversations – Dr. Charlie Chen
1500h – 1545h One Patient’s Personal Review of Commendations and Areas for Improvement in Cancer Care – Ms. Sharon Mallon
1600 – 1700h Registration and Welcome Reception- Heritage Hall
1700 – 1710h Opening Remarks – Dr. Wendy Lam, Dr. Laurie Sehn – Mt. Temple Ballroom
MYELOMA SESSION – Mt. Temple Ballroom
Chairs: Dr. Irwin Sandhu and Dr. Darrell White
1710 – 1730h Controversies in Transplant Eligible Myeloma Patients – Dr. Saad Usmani
1730 – 1750h Considerations for Next Therapies After AntiCD38 Monoclonal Antibodies – Dr. Alissa Visram
1750 – 1820h Best Practice Integrating CART and Bispecifics Into Our Clinics – Dr. Saad Usmani
1820 – 1840h Aligning Real World Data with Clinical Trials in Myeloma – Dr. Alissa Visram
1840 – 1925h Panel – Challenging Myeloma Cases
Chairs: Dr. Irwin Sandhu, Dr. Darrell White
Panel: Dr. Saad Usmani, Dr. Alissa Visram
1930h – Dinner

SATURDAY, MARCH 23, 2024

CLL SESSION – Mt. Temple Ballroom
Chair Dr. Julie Stakiw
0630 – 0700h Breakfast
0700 – 0705h Welcome and Introductions –
0705 – 0725h Who/When to Start CLL Treatment in the Era of Highly Effective Therapy? – Dr. Deborah Stephens
0725 – 0750h Treatment for Newly Diagnosed CLL – Dr. Othman Al-Sawaf
0750 – 0820h Treatment for Relapsed/Refractory CLL – Dr. Alina Gerrie
0820 – 0840h Overcoming Resistance in CLL – Dr. Othman Al-Sawaf
0840 – 0900h What’s new in Richter’s Syndrome? – Dr. Deborah Stephens
0900 – 1000h Panel – Challenging CLL Cases
Chair: Dr. Julie Stakiw
Panel: Dr. Othman Al-Sawaf, Dr. Alina Gerrie, Dr. Deborah Stephens
1300 – 1645h Young Investigators’ Poster and Oral Presentations
LYMPHOMA SESSION – Mt. Temple Ballroom
Chair: Dr. Wendy Lam
1700 – Welcome and Introductions –
1700 – 1705h Young Investigators Presentation of Best Poster – Dr. Pam Skrabek
1705 – 1735h Management of Hodgkin Lymphoma in the Era of Novel Therapy – Dr. Michael Crump
1735 – 1755h Promise of Circulating Tumour DNA in Lymphoma – Dr. David Scott
1755 – 1820h Post CAR T-Cell Therapy Care – Dr. Kevin Hay
1820 – 1845h Best of ASH – Dr. Nathalie Johnson
1845 – 1920h Panel – Challenging Lymphoma Cases
Chair: Dr. Wendy Lam
Panel: Dr. Michael Crump, Dr. David Scott, Dr. Kevin Hay, Dr. Nathalie Johnson
19:30 – Dinner

SUNDAY, MARCH 24, 2024

LYMPHOMA SESSION – Mt. Temple Ballroom
Chair: Dr. Pam Skrabek
0630 – 0700h Breakfast
0700 – 0705h Welcome and Introductions –
0705 – 0735h Molecular Subtyping of DLBCL, What is Clinically Relevant and What is Dark Zone Lymphoma – Dr. David Scott
0735 – 0805h What is the Worldwide Standard for Untreated LBCL? – Dr. Michael Dickinson
0805 – 0835h The Evolving Algorithm for R/R LBCL – Dr. Laurie Sehn
0835 – 0905h Use of Bispecifics in Lymphoma – Dr. Michael Dickinson
0905 – 0955h Panel – Challenging Lymphoma Cases
Chair: Dr. Michael Crump
Panel: Dr. Michael Dickinson, Dr. Kevin Hay, Dr. David Scott, Dr. Laurie Sehn
0955 – 1000h Closing Remarks – Dr. Laurie Sehn, Dr. Wendy Lam